JP2019524745A5 - - Google Patents

Download PDF

Info

Publication number
JP2019524745A5
JP2019524745A5 JP2019502697A JP2019502697A JP2019524745A5 JP 2019524745 A5 JP2019524745 A5 JP 2019524745A5 JP 2019502697 A JP2019502697 A JP 2019502697A JP 2019502697 A JP2019502697 A JP 2019502697A JP 2019524745 A5 JP2019524745 A5 JP 2019524745A5
Authority
JP
Japan
Prior art keywords
protein
polypeptide
human
binding polypeptide
binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019502697A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019524745A (ja
JP7254016B2 (ja
Filing date
Publication date
Priority claimed from GB1612643.5A external-priority patent/GB2552473A/en
Application filed filed Critical
Publication of JP2019524745A publication Critical patent/JP2019524745A/ja
Publication of JP2019524745A5 publication Critical patent/JP2019524745A5/ja
Priority to JP2022192884A priority Critical patent/JP2023026440A/ja
Application granted granted Critical
Publication of JP7254016B2 publication Critical patent/JP7254016B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019502697A 2016-07-21 2017-07-21 Fc結合能力を有する融合タンパク質を含む細胞外小胞 Active JP7254016B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022192884A JP2023026440A (ja) 2016-07-21 2022-12-01 Fc結合能力を有する融合タンパク質を含む細胞外小胞

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1612643.5A GB2552473A (en) 2016-07-21 2016-07-21 Surface decoration of extracellular vesicles
GB1612643.5 2016-07-21
PCT/EP2017/068476 WO2018015535A1 (en) 2016-07-21 2017-07-21 Extracellular vesicle comprising a fusion protein having fc binding capacity

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022192884A Division JP2023026440A (ja) 2016-07-21 2022-12-01 Fc結合能力を有する融合タンパク質を含む細胞外小胞

Publications (3)

Publication Number Publication Date
JP2019524745A JP2019524745A (ja) 2019-09-05
JP2019524745A5 true JP2019524745A5 (cg-RX-API-DMAC7.html) 2020-08-27
JP7254016B2 JP7254016B2 (ja) 2023-04-07

Family

ID=56894359

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2019502253A Expired - Fee Related JP7140743B2 (ja) 2016-07-21 2017-07-21 Fc結合能を有する融合タンパク質を含む細胞外小胞の使用
JP2019502697A Active JP7254016B2 (ja) 2016-07-21 2017-07-21 Fc結合能力を有する融合タンパク質を含む細胞外小胞
JP2022084613A Pending JP2022117998A (ja) 2016-07-21 2022-05-24 Fc結合能を有する融合タンパク質を含む細胞外小胞の使用
JP2022192884A Withdrawn JP2023026440A (ja) 2016-07-21 2022-12-01 Fc結合能力を有する融合タンパク質を含む細胞外小胞

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2019502253A Expired - Fee Related JP7140743B2 (ja) 2016-07-21 2017-07-21 Fc結合能を有する融合タンパク質を含む細胞外小胞の使用

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2022084613A Pending JP2022117998A (ja) 2016-07-21 2022-05-24 Fc結合能を有する融合タンパク質を含む細胞外小胞の使用
JP2022192884A Withdrawn JP2023026440A (ja) 2016-07-21 2022-12-01 Fc結合能力を有する融合タンパク質を含む細胞外小胞

Country Status (12)

Country Link
US (3) US11236143B2 (cg-RX-API-DMAC7.html)
EP (3) EP4299137A3 (cg-RX-API-DMAC7.html)
JP (4) JP7140743B2 (cg-RX-API-DMAC7.html)
KR (2) KR102636776B1 (cg-RX-API-DMAC7.html)
CN (2) CN109689097B (cg-RX-API-DMAC7.html)
AU (2) AU2017299214A1 (cg-RX-API-DMAC7.html)
BR (2) BR112019001108A2 (cg-RX-API-DMAC7.html)
CA (2) CA3031183A1 (cg-RX-API-DMAC7.html)
GB (1) GB2552473A (cg-RX-API-DMAC7.html)
MX (2) MX2019000863A (cg-RX-API-DMAC7.html)
SG (4) SG10202100598RA (cg-RX-API-DMAC7.html)
WO (2) WO2018015535A1 (cg-RX-API-DMAC7.html)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012040623A2 (en) 2010-09-24 2012-03-29 The Brigham And Women's Hospital, Inc. Nanostructured gels capable of controlled release of encapsulated agents
GB2552774A (en) * 2016-07-12 2018-02-14 Evox Therapeutics Ltd EV-Mediated delivery of binding protein-small molecule conjugates
GB2552473A (en) * 2016-07-21 2018-01-31 Evox Therapeutics Ltd Surface decoration of extracellular vesicles
WO2018144991A1 (en) 2017-02-03 2018-08-09 The Brigham And Women's Hospital, Inc. Self-assembled gels formed with anti-retroviral drugs, prodrugs thereof, and pharmaceutical uses thereof
GB201702863D0 (en) * 2017-02-22 2017-04-05 Evox Therapeutics Ltd Improved loading of EVs with therapeutic proteins
WO2019032628A1 (en) 2017-08-07 2019-02-14 The Regents Of The University Of California GENERATING PLATFORM FOR SAFE CELLULAR THERAPEUTIC AGENTS
GB201717446D0 (en) 2017-10-24 2017-12-06 Evox Therapeutics Ltd Affinity purification of engineering extracellular vesicles
GB201804291D0 (en) * 2018-03-16 2018-05-02 Evox Therapeutics Ltd Cell-mediated exosome delivery
US20190307885A1 (en) 2018-04-04 2019-10-10 Alivio Therapeutics, Inc. Self-assembled gels for controlled delivery of biologics and methods of making thereof
TWI770396B (zh) * 2018-06-28 2022-07-11 中央研究院 合成多肽及其用途
KR102917499B1 (ko) 2018-07-20 2026-01-26 더 보드 오브 트러스티스 오브 더 리랜드 스탠포드 쥬니어 유니버시티 백혈병 억제 인자 활성을 억제하기 위한 가용성 폴리펩타이드 및 이의 사용 방법
GB201812992D0 (en) 2018-08-09 2018-09-26 Univ Greenwich Liposomes
BR112021002710A2 (pt) 2018-08-14 2021-11-16 Evercyte Gmbh Vesículas extracelulares específicas alvo (tev), uma preparação, uma proteína de superfície da vesícula extracelular específica alvo, um domínio extravesicular específico alvo da mesma. codificação de ácido nucleico, biblioteca de tev, preparação farmacêutica e sua utilização; métodos de produção
CN108998402B (zh) * 2018-08-28 2020-05-29 江南大学 一种重组枯草芽孢杆菌及其构建方法与应用
US20210317479A1 (en) 2018-09-06 2021-10-14 The Broad Institute, Inc. Nucleic acid assemblies for use in targeted delivery
SG11202103756XA (en) * 2018-10-19 2021-05-28 Ohio State Innovation Foundation Extracellular vesicles for targeted therapies against myeloid-derived suppressor cells
CN113166267A (zh) 2018-10-19 2021-07-23 俄亥俄州国家创新基金会 纳米工程化治疗性隐形细胞
JP7577335B2 (ja) 2018-10-19 2024-11-05 オハイオ・ステイト・イノベーション・ファウンデーション 肺炎症治療用のナノキャリア
CN113301914B (zh) * 2018-10-25 2026-02-03 尼希尔有限公司 用于治疗和预防纤维化的组合物和方法
CN113272426A (zh) * 2018-11-16 2021-08-17 医福斯治疗有限公司 用于尿素循环蛋白和核酸的替代的细胞外囊泡
SG11202107007VA (en) * 2018-12-27 2021-07-29 Akeso Biopharma Inc Antibody against human il-4ra and use thereof
JP2022519275A (ja) * 2019-02-04 2022-03-22 コディアック バイオサイエンシーズ, インコーポレイテッド エクソソーム操作のための膜タンパク質足場
US12357704B2 (en) 2019-05-06 2025-07-15 Thomas Malcolm Tailored hypoimmune nanovesicular delivery systems for cancer tumors
US20220259617A1 (en) * 2019-06-13 2022-08-18 The General Hospital Corporation Engineered human-endogenous virus-like particles and methods of use thereof for delivery to cells
WO2020249757A1 (en) * 2019-06-14 2020-12-17 Philogen S.P.A Immunoconjugates comprising a single chain diabody and interleukin-15 or interleukin-15 and a sushi domain of interleukin-15 receptor alpha
AU2020298314A1 (en) * 2019-06-21 2022-02-03 Entelexo Biotherapeutics Inc. Platforms, compositions, and methods for therapeutics delivery
JP7898376B2 (ja) * 2019-08-06 2026-07-31 オハイオ・ステイト・イノベーション・ファウンデーション 治療用細胞外小胞
EP3973969A4 (en) * 2019-09-02 2023-07-12 Kyungpook National University Industry-Academic Cooperation Foundation COMPOSITION FOR THE PREVENTION OR TREATMENT OF CANCER USING IL-2 EXTRACELLULAR SURFACE EXPRESSION VESICLES AS AN ACTIVE AGENT
CN115942957A (zh) * 2019-11-04 2023-04-07 阿鲁纳生物股份公司 细胞外囊泡及其用于抗体递送的用途
CN112941028A (zh) * 2019-12-09 2021-06-11 上海细胞治疗集团有限公司 纳米抗体基因修饰的间充质干细胞及其制备方法与应用
KR20220139926A (ko) 2020-02-05 2022-10-17 다이아뎀 바이오쎄라퓨틱스 인크 인공 시냅스
WO2021211460A1 (en) * 2020-04-13 2021-10-21 City Of Hope Cell-receptor targeted exosomes
CN111544453B (zh) * 2020-04-27 2021-01-22 高连如 一种包含三种血管再生属性的混合干细胞注射液及其制备方法
CN111560352B (zh) * 2020-06-02 2023-03-24 新疆农业大学 一种病毒样囊泡及其制备方法和应用
CN111905105B (zh) * 2020-07-02 2023-05-05 华南师范大学 一种用于癌症靶向治疗的蛋白类纳米药物及其制备方法
CN112111513A (zh) * 2020-07-17 2020-12-22 深圳市第二人民医院 基于外泌体平台的新冠病毒疫苗制备方法
BR112023001272A2 (pt) 2020-07-24 2023-04-04 Massachusetts Gen Hospital Partículas semelhantes a vírus aprimoradas e métodos de uso das mesmas para entrega às células
CN113967254B (zh) * 2020-08-04 2022-08-12 华南理工大学 用于多特异性抗体递送的细胞膜包覆型纳米适配子及应用
JP2023536665A (ja) * 2020-08-05 2023-08-28 オハイオ・ステイト・イノベーション・ファウンデーション アダプターポリペプチドおよびその使用方法
CN112285195B (zh) * 2020-10-27 2021-08-10 江南大学 一种牛奶外泌体的特征性糖蛋白标志物和牛奶外泌体的特征性标志物分离方法
WO2022149779A1 (ko) * 2021-01-11 2022-07-14 주식회사 엑소코바이오 과발현된 Fc 수용체 또는 이의 일부를 포함하는 엑소좀 및 이의 제조방법
KR102252325B1 (ko) * 2021-01-14 2021-05-14 이장호 태아 유래 태초 면역글로불린을 포함하는 세포외소포의 제조방법
WO2022158836A1 (ko) * 2021-01-21 2022-07-28 주식회사 엑소코바이오 목적 단백질 또는 펩타이드가 융합가능한 Fc 수용체 또는 이의 일부를 포함하는 재조합 엑소좀 및 이의 용도
WO2022219075A2 (en) * 2021-04-14 2022-10-20 Anjarium Biosciences Ag Peptides, nanovesicles, and uses thereof for drug delivery
EP4323396A1 (en) * 2021-04-14 2024-02-21 Anjarium Biosciences AG Fc-derived polypeptides
JP2024518732A (ja) * 2021-04-23 2024-05-02 スポット バイオシステムズ リミテッド 生体分子がロードされた細胞外小胞
GB202107182D0 (en) * 2021-05-19 2021-06-30 Evox Therapeutics Ltd Nanoparticle delivery system for production of engineered extracellular vesicles
EP4355304A4 (en) * 2021-06-17 2025-04-30 Malcolm, Thomas PERSONALIZED HYPOIMMUNE NANOVESICULAR DELIVERY SYSTEMS FOR CANCERS, INHERITED DISEASES AND INFECTIOUS DISEASES
CN115770302A (zh) * 2021-08-13 2023-03-10 南京大学 一种rna递送系统及其应用
CN113599516B (zh) * 2021-08-16 2022-02-18 上海蒙彼利生物技术有限公司 制备外泌体方法及其药物组合物在组织修复中的应用
KR102577502B1 (ko) * 2021-09-08 2023-09-13 주식회사 꿈랩 생체분자의 안정적 발현 및 전달을 위한 플라스미드 플랫폼
CN113897387B (zh) * 2021-10-09 2023-09-05 深圳市汉科生命工程有限公司 一种具有促进毛发再生功能的基因重组msc及其外泌体样纳米材料的制备方法和应用
WO2023076768A1 (en) * 2021-10-26 2023-05-04 Navicure Biopharmaceuticals Limited Combination therapies against cancer and infectious diseases
CN116218780A (zh) * 2021-12-03 2023-06-06 洪明奇 外泌体的生产及其用途
CN114107253B (zh) * 2021-12-17 2024-03-15 复旦大学附属华山医院 一种利用工程细胞进行基因编辑的系统及方法
CN114236113B (zh) * 2021-12-21 2023-07-21 南京农业大学 一种2,4-滴的即用型免疫传感器
WO2023133425A1 (en) * 2022-01-04 2023-07-13 The Broad Institute, Inc. Compositions and methods for delivering cargo to a target cell
WO2023196586A1 (en) * 2022-04-07 2023-10-12 The Regents Of The University Of Michigan Methods and devices for screening extracellular vesicles
CN116903712A (zh) * 2022-04-12 2023-10-20 四川大学华西医院 一种人源IgG结合肽及其用途
WO2024064748A2 (en) * 2022-09-20 2024-03-28 North Carolina State University Compositions and methods related to exosomal delivery of therapeutic agents
CN116179582A (zh) * 2022-09-27 2023-05-30 南京医事达生物科技有限公司 一种通用型基因重组蛋白质a亲和纯化填料制备方法和应用
CN117802045A (zh) * 2022-09-30 2024-04-02 北京恩康医药有限公司 一种工程化细胞外囊泡的构建及其应用
CN115873905A (zh) * 2022-11-15 2023-03-31 重庆医科大学附属儿童医院 一种gd2纳米抗体靶向修饰的类外泌体的新型药物载体的制备方法
KR102929157B1 (ko) 2023-03-08 2026-02-23 차이나 메디칼 유니버시티 엑소좀의 생산 및 이의 용도
KR20240158824A (ko) * 2023-04-26 2024-11-05 (주)인엑소플랫 면역글로불린 Fc 영역 또는 이의 변이체를 포함하는 재조합 세포외 소포체 및 이를 이용한 세포외 소포체의 분리 방법
KR20240159543A (ko) * 2023-04-28 2024-11-05 연세대학교 산학협력단 유방암 유래 엑소좀 또는 세포외 소포체 분리 방법
GB202307239D0 (en) 2023-05-15 2023-06-28 Evox Therapeutics Ltd Gene therapies for Phenylketonuria
CN119120376A (zh) * 2023-07-10 2024-12-13 浙江大学医学院附属第一医院 一种用于清除致病抗体的嵌合基因工程化纳米囊泡及其制备方法、应用
EP4784736A2 (en) 2023-09-29 2026-08-05 Evox Therapeutics Limited Polypeptides comprising inteins for engineered evs
WO2025102257A1 (zh) * 2023-11-15 2025-05-22 深圳先进技术研究院 一种靶向子宫工程化细胞外囊泡的制备方法及其应用
WO2025217863A1 (zh) * 2024-04-18 2025-10-23 苏州鲲石一号生物科技有限公司 Gas6融合蛋白及其制备方法与应用
CN118725135B (zh) * 2024-09-02 2025-02-07 中国科学院苏州纳米技术与纳米仿生研究所 外泌体的改造方法
CN119019494B (zh) * 2024-10-28 2025-02-07 广州飞来爱生命科技有限公司 一种治疗心梗的脐带间充质干细胞及其制备方法和应用
GB2702728A (en) 2024-10-29 2026-06-24 Evox Therapeutics Ltd Crispr rna molecules for improved ev-mediated delivery of cas12 rnp complexes
AU2026200047A1 (en) * 2025-01-10 2026-07-30 China Medical University Central nervous system targeting pharmaceutical composition

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4090299A (en) * 1998-05-20 1999-12-06 Sdg, Inc. Liposomal delivery complex
US20040241176A1 (en) * 2000-04-27 2004-12-02 Ap Cells. Inc. Method of producing membrane vesicles
US20070128117A1 (en) * 2003-02-04 2007-06-07 Bracco International B.V. Ultrasound contrast agents and process for the preparation thereof
JP2007295929A (ja) * 2006-04-05 2007-11-15 Geno Membrane:Kk イヌBsep遺伝子
EP2198033A4 (en) * 2007-08-30 2011-05-25 Virexx Medical Corp ANTIGENIC COMPOSITIONS AND USE THEREOF IN THE TARGETED INTRODUCTION OF NUCLEIC ACIDS
AU2008303057B2 (en) * 2007-09-24 2014-09-04 The University Of Queensland Molecular delivery vesicle
PT2419144T (pt) * 2009-04-17 2019-09-16 Univ Oxford Innovation Ltd Composição para a administração de material genético
SG191233A1 (en) * 2010-12-23 2013-07-31 Janssen Biotech Inc Active protease-resistant antibody fc mutants
DK2675474T3 (en) * 2011-02-15 2019-04-23 Vaxiion Therapeutics Llc THERAPEUTIC COMPOSITIONS AND PROCEDURES FOR TARGETED ADMINISTRATION OF BIOACTIVE MOLECULES BY BACK-TERIAL MINICLES BASED ON ANTIBODY AND FC-CONTAINING TAR-GETING MOLECULES
GB201121069D0 (en) * 2011-12-07 2012-01-18 Isis Innovation Delivery system
GB201121070D0 (en) * 2011-12-07 2012-01-18 Isis Innovation composition for delivery of biotherapeutics
EP2983721B2 (en) * 2013-04-12 2021-01-20 Evox Therapeutics Limited Therapeutic delivery vesicles
WO2015002956A1 (en) 2013-07-01 2015-01-08 Ohio State Innovation Foundation Exosome delivery system
US10538570B2 (en) * 2013-09-30 2020-01-21 Northwestern University Targeted and modular exosome loading system
WO2015058148A1 (en) * 2013-10-17 2015-04-23 Children's Hospital Los Angeles Antibody dependent exosome therapy
WO2015143113A1 (en) * 2014-03-20 2015-09-24 Barb Ariel Cohen Preparations of derived extracellular vesicles, assays, and methods to modify therapeutic outcomes using such preparations
GB2552473A (en) * 2016-07-21 2018-01-31 Evox Therapeutics Ltd Surface decoration of extracellular vesicles

Similar Documents

Publication Publication Date Title
JP7423511B2 (ja) Pd-1およびpd-l1結合物質
JP7347899B2 (ja) Cd8結合物質
KR102877915B1 (ko) 섬유아세포 결합제 및 이의 용도
KR102659140B1 (ko) Clec9a 결합제 및 그의 용도
Shalaby et al. Development of humanized bispecific antibodies reactive with cytotoxic lymphocytes and tumor cells overexpressing the HER2 protooncogene.
CN107353342B (zh) PDGF受体β结合多肽
AU745965B2 (en) Anti-GPIIb/IIIa recombinant antibodies
JP2019137675A5 (cg-RX-API-DMAC7.html)
JP7773372B2 (ja) 線維芽細胞活性化タンパク質結合物質およびその使用
US20020018749A1 (en) High avidity polyvalent and polyspecific reagents
US20080152586A1 (en) High avidity polyvalent and polyspecific reagents
JP2019520852A5 (cg-RX-API-DMAC7.html)
JP2019521140A (ja) 結合タンパク質−小分子コンジュゲートのev媒介送達
NO322252B1 (no) Anti-EGFR-enkeltkjede-Fv-er, DNA-molekyl som koder for denne, fremgangsmate for fremstilling av denne, kimert anti-EGFR-antistoff, fremgangsmate for fremstilling av helt kimert anti-EGFR-antistoff, farmasoytisk preparat som omfatter disse og anvendelse av disse for fremstilling av legemiddel mot tumorer.
JP2012034668A (ja) ヒト型化抗egfr抗体リジン置換可変領域断片及びその利用
BR112021007334A2 (pt) anticorpo anti-l1cam ou fragmento de ligação ao antígeno do mesmo, e receptor de antígeno quimérico compreendendo o mesmo
JP7644151B2 (ja) 抗pd-1抗体および融合タンパク質
JP2024019419A (ja) CD137抗原結合部位を含むFc結合断片
US20240400716A1 (en) Molecules that bind to prostate specific membrane antigen (psma) polypeptides
AU2015239606C1 (en) Antibodies against HPA-1a
KR20250158012A (ko) 키메라 항원 수용체
JP7858057B2 (ja) Cd94/nkg2aヘテロ二量体ポリペプチドに結合する分子
US20240392037A1 (en) Molecules that bind to neutrophil elastase polypeptides
EP4658312A2 (en) Molecules that bind to follistatin polypeptides
KR20240006506A (ko) 항-백시니아 바이러스 항원 항체 및 관련 조성물 및 방법